Please assess the completion status of the following clinical trial:

Trial Title: Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 9.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of non-psychotic Major depressive disorder~* HAMD-17 score 14 or greater~* Age of 18 or greater and 65 or less~Exclusion Criteria:~* patients with current or past history of diagnosis of bipolar disorder, schizophrenia, schizoaffective disorder, or psychotic disorder NOS~* patients with current psychotic features, eating disorders or obsessive-compulsive disorder~* patients with neurological disorder~* patients with medical condition that could interfere with everyday life activities~* pregnant or lactating women,~* patients with current other DSM-IV TR Axis I diagnosis other than MDD which needs inpatient care~* patients who treated with ECT for current depressive episode~* insufficient information of past treatment for current depressive episode~* patients who posed a serious suicidal risk.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Paroxetine (Type: EXPERIMENTAL): Paroxetine monotherapy
- Escitalopram (Type: ACTIVE_COMPARATOR): Escitalopram monotherapy
- Venlafaxine (Type: ACTIVE_COMPARATOR): Venlafaxine monotherapy
- Paroxetine+Bupropion (Type: ACTIVE_COMPARATOR): None
- Paroxetine+Lamotrigine (Type: ACTIVE_COMPARATOR): None
- Paroxetine+Lithium (Type: ACTIVE_COMPARATOR): None
- escitalopram+mirtazapine (Type: ACTIVE_COMPARATOR): None
- Escitalopram+Aripiprazole (Type: ACTIVE_COMPARATOR): None
- Paroxetine + Venlafaxine (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).